PYC 2.70% 19.0¢ pyc therapeutics limited

Ann: Retina Target Engagement Confirmed in Large Eye, page-64

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 5,380 Posts.
    lightbulb Created with Sketch. 692
    Intellua 9.7 billion mc looking for ways to get their gene editing technology into cells. I wonder if they would be interested in pyc tech.

    "But Leonard is not ruling out potential deals that could bring new technology into the Intellia fold—especially anything that can improve on delivery mechanisms in gene editing.“We're always looking for technology that can be brought to bear to genome editing,” he said. “We think we know what needs to be done once you get inside a cell, and, if there's a particular gene or set of genes that need to be manipulated, we think we can do that as well as anybody on Earth, as far as we know."But delivery is something that can augment the work that we do. If people have technologies that can add to that, we'd always be interested in learning about that.”




    https://www.fiercebiotech.com/biotech/intellia-ceo-john-loenard-potential-m-a-dealmaking-gene-editing-fierce-biotech-cell-gene
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
0.005(2.70%)
Mkt cap ! $886.5M
Open High Low Value Volume
19.0¢ 19.0¢ 18.0¢ $125.5K 667.2K

Buyers (Bids)

No. Vol. Price($)
2 11936 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 40292 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.